Stock News
Clever, Personable, and Unconventional: A Refreshing Take on Blogging
Adzenys and Cotempla: A Game-Changer for ADHD Treatment in Canada Health Canada’s approval of Adzenys and Cotempla as the only orally disintegrating, extended-release tablets for the treatment of ADHD in Canada is a significant milestone. This collaboration between Aytu BioPharma, Inc. and Lupin Pharma Canada Ltd marks a new era in ADHD treatment options for…
Revolutionizing the Water Industry: H2O Innovation Acquires NextEra Distributed Water
Welcome to the Future of Wastewater Treatment and Reuse A New Venture for H2O Innovation Quebec City–(BUSINESS WIRE)–H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) today announced that it has acquired NextEra Distributed Water (the “Business”) via a carve-out transaction. Going forward, the Business and its portfolio of sustainable wastewater treatment and reuse projects will…
Discover the Latest Innovations: Inovio to Showcase at Upcoming Scientific Conferences
INOVIO Announces Participation in Scientific Conferences AACR Special Conference in Cancer Research INOVIO, a biotechnology company, will present a poster at the AACR Special Conference in Cancer Research on October 19, 2024. Dr. Matthew Morrow, VP of Translational Sciences at INOVIO, will present on the reduction in surgical interventions for the treatment of Recurrent Respiratory…
Goodbye Brain Tumor: BriaCell’s Breakthrough Treatment Resolves Eye-Bulging Metastasis in Breast Cancer Patient
Welcome to the Future of Cancer Care Exciting News from BriaCell Therapeutics Corp. PHILADELPHIA and VANCOUVER, British Columbia, Oct. 01, 2024 (GLOBE NEWSWIRE) BriaCell Therapeutics Corp. has just announced a groundbreaking development in the world of cancer treatment. In a recent Phase 2 study, a patient with temporal lobe breast cancer metastasis showed a dramatic…
Breaking News: Costamare Inc. Announces Quarterly Dividend for Preferred and Common Stock!
Cash Dividends Declared by Costamare Inc. MONACO, Oct. 01, 2024 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company”) (NYSE: CMRE) has declared cash dividends of US $0.476563 per share on its 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock (the “Series B Preferred Stock”) (NYSE: CMRE PR B), US $0.531250 per share on its 8.50% Series…
Score Big Savings: Ollie’s Bargain Outlet Snags Former Big Lots Locations!
Welcome to the Bargain Bonanza! What’s the Scoop on Ollie’s Bargain Outlet Holdings, Inc.? Well, folks, it looks like Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) is making some big moves in the world of retail! The Company recently announced that they were the winning bidder in a bankruptcy sale process to acquire seven former…
Uniquely Quirky and Engaging: A Blog-Friendly Rewrite of ‘Accesswire’s Article on Maximizing Reader Engagement’
Charmingly Eccentric: The Story of Vanda Pharmaceuticals Inc. A Tale of Resilience and Innovation Founded in 2003, Vanda Pharmaceuticals Inc. has been a pioneer in the field of biopharmaceuticals, dedicated to developing novel treatments for a variety of medical conditions. With a focus on neurological and psychiatric disorders, Vanda has made significant strides in improving…
Unlock the Scoop: The Inside Story on Article 926098 (and Why You’ll Want to Read It in HTML)
Welcome to the Levi & Korsinsky Blog! What’s the Buzz About Progyny, Inc.? Hey there, fellow investors! Big news on the horizon – Levi & Korsinsky has officially kicked off an investigation into Progyny, Inc. (NASDAQ:PGNY) for potential breaches of federal securities laws. What’s got everyone talking? Well, Progyny recently dropped a bombshell in their…